{"entity":{"type":"insider","cik":"0001477056","url":"/insider/0001477056","json_url":"/insider/0001477056.json","name":"Bencich John","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":7,"first":"2015-08-20","last":"2024-03-06","span_basis":"filed_date"},"name_variants":[{"name":"Bencich John","source":"filing","n_filings":7,"first_seen":"2015-08-20","last_seen":"2024-03-06"}],"transactions":[{"id":2849749,"accession":"0000950170-24-027243","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-027243","line_url":"/filing/0000950170-24-027243#line-1","is_derivative":false,"issuer_cik":"0000949858","issuer_name":"ACHIEVE LIFE SCIENCES, INC.","issuer_ticker":"ACHV","issuer_name_source":null,"issuer_url":"/issuer/0000949858","owner_cik":"0001477056","owner_name":"Bencich John","owner_display_name":"Bencich John","owner_url":"/insider/0001477056","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.585,"price_display":"4.58","price_state":"stated","total_value":45850.0,"total_display":"45,850.00","total_whole":"45,850","shares_owned_after":76724.0,"shares_owned_after_display":"76,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-06","scope":"insider"},{"id":7870150,"accession":"0001209191-23-033392","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-033392","line_url":"/filing/0001209191-23-033392#line-1","is_derivative":false,"issuer_cik":"0000949858","issuer_name":"ACHIEVE LIFE SCIENCES, INC.","issuer_ticker":"ACHV","issuer_name_source":null,"issuer_url":"/issuer/0000949858","owner_cik":"0001477056","owner_name":"Bencich John","owner_display_name":"Bencich John","owner_url":"/insider/0001477056","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.5,"price_display":"5.50","price_state":"stated","total_value":27500.0,"total_display":"27,500.00","total_whole":"27,500","shares_owned_after":66730.0,"shares_owned_after_display":"66,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-30","filed_date":"2023-06-01","scope":"insider"},{"id":6458098,"accession":"0001209191-22-058064","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-058064","line_url":"/filing/0001209191-22-058064#line-1","is_derivative":false,"issuer_cik":"0000949858","issuer_name":"ACHIEVE LIFE SCIENCES, INC.","issuer_ticker":"ACHV","issuer_name_source":null,"issuer_url":"/issuer/0000949858","owner_cik":"0001477056","owner_name":"Bencich John","owner_display_name":"Bencich John","owner_url":"/insider/0001477056","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22000.0,"shares_display":"22,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":36920.0,"shares_owned_after_display":"36,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-18","filed_date":"2022-11-21","scope":"insider"},{"id":5380598,"accession":"0001209191-21-036229","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-036229","line_url":"/filing/0001209191-21-036229#line-1","is_derivative":false,"issuer_cik":"0000949858","issuer_name":"ACHIEVE LIFE SCIENCES, INC.","issuer_ticker":"ACHV","issuer_name_source":null,"issuer_url":"/issuer/0000949858","owner_cik":"0001477056","owner_name":"Bencich John","owner_display_name":"Bencich John","owner_url":"/insider/0001477056","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":42000.0,"total_display":"42,000.00","total_whole":"42,000","shares_owned_after":6141.0,"shares_owned_after_display":"6,141","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-27","filed_date":"2021-05-27","scope":"insider"},{"id":3176037,"accession":"0001209191-16-138385","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-138385","line_url":"/filing/0001209191-16-138385#line-2","is_derivative":false,"issuer_cik":"0000949858","issuer_name":"ONCOGENEX PHARMACEUTICALS, INC.","issuer_ticker":"OGXI","issuer_name_source":null,"issuer_url":"/issuer/0000949858","owner_cik":"0001477056","owner_name":"Bencich John","owner_display_name":"Bencich John","owner_url":"/insider/0001477056","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1380.0,"shares_display":"1,380","price_per_share":0.57,"price_display":"0.57","price_state":"stated","total_value":786.6,"total_display":"786.60","total_whole":"787","shares_owned_after":9484.0,"shares_owned_after_display":"9,484","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-19","filed_date":"2016-08-23","scope":"insider"},{"id":3290833,"accession":"0001209191-16-108927","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-108927","line_url":"/filing/0001209191-16-108927#line-2","is_derivative":false,"issuer_cik":"0000949858","issuer_name":"ONCOGENEX PHARMACEUTICALS, INC.","issuer_ticker":"OGXI","issuer_name_source":null,"issuer_url":"/issuer/0000949858","owner_cik":"0001477056","owner_name":"Bencich John","owner_display_name":"Bencich John","owner_url":"/insider/0001477056","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":834.0,"shares_display":"834","price_per_share":0.83,"price_display":"0.83","price_state":"stated","total_value":692.22,"total_display":"692.22","total_whole":"692","shares_owned_after":5864.0,"shares_owned_after_display":"5,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-15","filed_date":"2016-03-16","scope":"insider"},{"id":8943767,"accession":"0001209191-15-067054","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-067054","line_url":"/filing/0001209191-15-067054#line-2","is_derivative":false,"issuer_cik":"0000949858","issuer_name":"ONCOGENEX PHARMACEUTICALS, INC.","issuer_ticker":"OGXI","issuer_name_source":null,"issuer_url":"/issuer/0000949858","owner_cik":"0001477056","owner_name":"Bencich John","owner_display_name":"Bencich John","owner_url":"/insider/0001477056","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1427.0,"shares_display":"1,427","price_per_share":2.76,"price_display":"2.76","price_state":"stated","total_value":3938.52,"total_display":"3,938.52","total_whole":"3,939","shares_owned_after":3573.0,"shares_owned_after_display":"3,573","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-18","filed_date":"2015-08-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000949858","name":"ACHIEVE LIFE SCIENCES, INC.","url":"/issuer/0000949858","role":"Director, Officer (CEO)","n_filings":7,"first_seen":"2015-08-20","last_seen":"2024-03-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001477056","retrieved_at":"2026-08-27T01:09:30+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}